Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Symptom tracking Make a note of any side effects such as nausea or changes in appetite to help you and your clinician understand how your body responds to GLP-1s
Daytime Protection: A morning dose maintains high antioxidant levels, helping your body defend against environmental toxins and oxidative stress throughout the day
But, as we all know, its tough to break old habits
Gastroparesis, often referred to as stomach paralysis or gastric obstruction, is a medical condition characterized by a significant delay in the movement of food from the stomach to the small intestine
"By shifting GLP-1 exposure toward the brain and away from the periphery, our technology directly addresses key limitations of current injectable and oral GLP-1 therapies." A next-generation GLP-1 strategy Current subcutaneous and oral GLP-1 receptor agonists generate high plasma levels but achieve only limited direct brain exposure, contributing to dose-limiting gastrointestinal side effects and restricting their broader use in CNS-driven indications
